Washington, D.C., – The December issues of two of the American Psychiatric Association’s journals, The American Journal of Psychiatry and Psychiatric Services are available online.

The December issue of The American Journal of Psychiatry focuses on new therapeutic approaches involving psychopharmacology, digital technology, and fMRI neurofeedback. The issue includes:

• Technology and Mental Health: State of the Art for Assessment and Treatment.
• Targeted Oral Naltrexone for Mild to Moderate Alcohol Use Disorder Among Sexual and Gender Minority Men: A Randomized Trial.
• Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial.
• Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results from a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis.
• Double-Blind, Sham-Controlled Randomized Trial Testing the Efficacy of fMRI Neurofeedback on Clinical and Cognitive Measures in Children With ADHD.

Psychiatric Services features research reports on issues related to the delivery of mental health services, especially for people with serious mental illness in community-based treatment programs. Its December issue features:

• Impact of the COVID-19 Pandemic on the Behavioral Health of People With Intellectual and Developmental Disabilities.
• Communication Over Incarceration: Improving Care Coordination Between Correctional and Community Mental Health Services.
• Racial and Ethnic Inequities in Inpatient Psychiatric Civil Commitment.
• Mental Health Conditions Among Children and Adolescents With a COVID-19 Diagnosis.
• Rapid and Deferred Help Seeking Among African American Parents of Children With Emotional and Behavioral Difficulties.
• Age-Associated Differences in Mental Distress Among Sexual and Gender Minority Adults.

Journalists who wish to access the publications should email [email protected].

American Psychiatric Association

The American Psychiatric Association, founded in 1844, is the oldest medical association in the country. The APA is also the largest psychiatric association in the world with more than 37,000 physician members specializing in the diagnosis, treatment, prevention, and research of mental illnesses. APA’s vision is to ensure access to quality psychiatric diagnosis and treatment. For more information, please visit www.psychiatry.org.